The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...
Between seven and eight million adults in the UK are thought to take the tablet every day and eating one fruit could cause issues ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class ...
A Peterborough shop’s licence has been revoked after large amounts of illegal products were seized. Officers carried out a ...
Sleeping sickness is no longer a health threat in Guinea, which may be a tipping point in the continent’s efforts to beat the ...
An international lineup of the world’s leading healthcare start-ups competed in the final of the Innov8 competition ...
The drugs were found in parcels sent from Thailand, USA, UK, Canada, and India, France and Spain and destined for various ...